Paolo Foa

1.8k total citations · 1 hit paper
36 papers, 1.4k citations indexed

About

Paolo Foa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, Paolo Foa has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 9 papers in Otorhinolaryngology. Recurrent topics in Paolo Foa's work include Head and Neck Cancer Studies (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Frailty in Older Adults (5 papers). Paolo Foa is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Frailty in Older Adults (5 papers). Paolo Foa collaborates with scholars based in Italy, United States and Germany. Paolo Foa's co-authors include Daris Ferrari, Andrea Luciani, S. Caldiera, Irene Floriani, Carla Codecà, Bruce Allen Bach, Eric Winquist, Makoto Tahara, Sylvie Rottey and Lisa Licitra and has published in prestigious journals such as Journal of Clinical Oncology, Water Research and Cancer Research.

In The Last Decade

Paolo Foa

36 papers receiving 1.3k citations

Hit Papers

Cisplatin and fluorouracil with or without panitumumab in... 2013 2026 2017 2021 2013 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
    2013 314 citations Jan B. Vermorken, Ірина Давиденко et al. The Lancet Oncology profile →

Peers

Paolo Foa
Daris Ferrari Italy
Thomas Kuhnt Germany
Boukje A. C. van Dijk Netherlands
Michael C. Cheung United States
L. Cerezo Spain
Stéphane Culine France
Giovanni Franchin Italy
Seong Yoon Yi South Korea
B. Stein Australia
Silke Tribius Germany
Daris Ferrari Italy
Paolo Foa
Citations per year, relative to Paolo Foa Paolo Foa (= 1×) peers Daris Ferrari

Countries citing papers authored by Paolo Foa

Since Specialization
Citations

This map shows the geographic impact of Paolo Foa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Foa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Foa more than expected).

Fields of papers citing papers by Paolo Foa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Foa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Foa. The network helps show where Paolo Foa may publish in the future.

Co-authorship network of co-authors of Paolo Foa

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Foa. A scholar is included among the top collaborators of Paolo Foa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Foa. Paolo Foa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrari, Daris, Carla Codecà, Giulia Viale, et al.. (2016). An unusual case of tracheo-pleural fistula and cardiac metastases in oropharyngeal carcinoma: a case report and review of the literature. PubMed. 1(1). 16–16. 2 indexed citations
2.
Ferrari, Daris, Carla Codecà, Giulia Viale, et al.. (2015). Anti-epidermal growth factor receptor skin toxicity. Anti-Cancer Drugs. 27(2). 144–146. 3 indexed citations
3.
Luciani, Andrea, Laura Biganzoli, Giuseppe Colloca, et al.. (2015). Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13). Journal of Geriatric Oncology. 6(4). 272–279. 62 indexed citations
4.
Ferrari, Daris, Carla Codecà, Nicolò Matteo Luca Battisti, et al.. (2014). Multimodality treatment of osteosarcoma of the jaw: a single institution experience. Medical Oncology. 31(9). 171–171. 21 indexed citations
5.
6.
Rimassa, Lorenza, Tiziana Pressiani, C. Boni, et al.. (2013). A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients With Advanced Hepatocellular Carcinoma. The Oncologist. 18(4). 379–380. 29 indexed citations
7.
Vermorken, Jan B., Ірина Давиденко, Lisa Licitra, et al.. (2013). Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial. The Lancet Oncology. 14(8). 697–710. 314 indexed citations breakdown →
8.
9.
Ferrari, Daris, Carla Codecà, Andrea Luciani, et al.. (2012). Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a western population. BMC Cancer. 12(1). 208–208. 49 indexed citations
10.
11.
Joss, Adriano, Paolo Foa, S. Koepke, et al.. (2011). Water reuse: >90% water yield in MBR/RO through concentrate recycling and CO2 addition as scaling control. Water Research. 45(18). 6141–6151. 57 indexed citations
12.
Luciani, Andrea, Tiziana Ascione, Carla Codecà, et al.. (2010). Detecting Disabilities in Older Patients With Cancer: Comparison Between Comprehensive Geriatric Assessment and Vulnerable Elders Survey-13. Journal of Clinical Oncology. 28(12). 2046–2050. 146 indexed citations
13.
Ferrari, Daris, Carla Codecà, Giuseppe Di Maria, et al.. (2009). A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer. Anti-Cancer Drugs. 20(3). 185–190. 21 indexed citations
14.
Ferrari, Daris, et al.. (2009). A review on the treatment of relapsed/metastatic head and neck cancer. Expert Opinion on Pharmacotherapy. 10(16). 2625–2632. 8 indexed citations
15.
Ferrari, Daris, Giuseppe Di Maria, Nicola Fazio, et al.. (2008). Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy. Anti-Cancer Drugs. 19(8). 837–840. 5 indexed citations
16.
Luciani, Andrea, Paul B. Jacobsen, Martine Extermann, et al.. (2008). Fatigue and Functional Dependence in Older Cancer Patients. American Journal of Clinical Oncology. 31(5). 424–430. 63 indexed citations
17.
Ferrari, Daris, Claudia Carbone, Luca Fumagalli, et al.. (2006). Gemcitabine and atrial fibrillation: a rare manifestation of chemotherapy toxicity. Anti-Cancer Drugs. 17(3). 359–361. 24 indexed citations
18.
Foa, Paolo, Mauro Pomati, Alessandra Iurlo, et al.. (1997). Polycythemia vera treated with recombinant interferon-alpha 2a: Evidence of a selective effect on the malignant clone. American Journal of Hematology. 56(2). 126–128. 28 indexed citations
19.
Iurlo, Alessandra, et al.. (1989). Chronic myelogenous leukemia following radiation therapy for testicular seminoma. Annals of Hematology. 59(6). 503–504. 10 indexed citations
20.
Foa, Paolo, et al.. (1987). Inhibitory activity of a synthetic pentapeptide on leukaemic myelopoiesis both in vitro and in vivo in rats. European Journal Of Haematology. 39(5). 399–403. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daris Ferrari Breakdown of academic impact, for papers by Thomas Kuhnt Breakdown of academic impact, for papers by Boukje A. C. van Dijk Breakdown of academic impact, for papers by Michael C. Cheung Breakdown of academic impact, for papers by L. Cerezo Breakdown of academic impact, for papers by Stéphane Culine Breakdown of academic impact, for papers by Giovanni Franchin Breakdown of academic impact, for papers by Seong Yoon Yi Breakdown of academic impact, for papers by B. Stein Breakdown of academic impact, for papers by Silke Tribius
Rankless by CCL
2026